Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Martek Biosciences

This article was originally published in The Tan Sheet

Executive Summary

Revenues for the fiscal third quarter ending July 31 reached $2.4 mil., an 86% increase over the prior year, the Columbia, Md. firm reports. Sales for the nine-months leapt 51% compared to the same period in 1999. Martek has been granted a European patent for the production, sale and use of arachidonic acid (ARA) in concentrations of at least 30%. The firm already holds a patent in Europe for docosahexaenoic acid (DHA) and markets the nutritional oils in infant formulas in over 60 countries. Martek is awaiting an FDA response to a GRAS notification for the use of DHA and ARA in infant formulas in the U.S

You may also be interested in...



DHA patent revoked

Martek Biosciences to appeal recent DHA patent revocation in Europe, firm says Oct. 12. Martek's patent was annulled by the European Patent Office at a recent hearing held in Munich, Germany following a challenge by several potential competitors. The infant formula and dietary supplement ingredients supplier recently received a separate European patent for the production, sale and use of ARA (1"The Tan Sheet" Sept. 25, In Brief)

DHA patent revoked

Martek Biosciences to appeal recent DHA patent revocation in Europe, firm says Oct. 12. Martek's patent was annulled by the European Patent Office at a recent hearing held in Munich, Germany following a challenge by several potential competitors. The infant formula and dietary supplement ingredients supplier recently received a separate European patent for the production, sale and use of ARA (1"The Tan Sheet" Sept. 25, In Brief)

DHA patent revoked

Martek Biosciences to appeal recent DHA patent revocation in Europe, firm says Oct. 12. Martek's patent was annulled by the European Patent Office at a recent hearing held in Munich, Germany following a challenge by several potential competitors. The infant formula and dietary supplement ingredients supplier recently received a separate European patent for the production, sale and use of ARA (1"The Tan Sheet" Sept. 25, In Brief)

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS091687

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel